Evaluation (WP3)

Evaluation allows for continuous improvement and sharing of
best practices across the network. For Endo-ERN members there is
self-evaluation annually, and an external review as part of the AMEQUIS
cycle, every 5 years.

Objectives: Ensure consistent care for patients with rare endocrine
conditions within and without the Endo-ERN network.